ZENA vs ZEO

ZENA exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price/Book ratio of -10.42, indicating negative shareholders' equity. While revenue growth is astronomical at 1225%, it has failed to translate into profitability, with operating margins at -110.49% and consistent, massive earnings misses. The current price of $2.09 trades at a significant premium to the growth-based intrinsic value of $0.28. Overall, the company shows signs of a high-growth venture that is burning cash rapidly without a clear path to sustainable earnings.

ZEO exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -16.44, indicating negative shareholders' equity. The company is struggling with negative profitability (ROE -43.43%) and stagnant to declining revenue growth (-0.40% YoY). Despite a strong current ratio, the long-term price trajectory is catastrophic, with a 90.8% decline over five years. The combination of fundamental decay and bearish insider activity suggests a high risk of further devaluation.